ARCHIVES

ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies

This article is from The Cancer Letter archive.

Vol. 38 No. 25 | June 22, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI To File Heroin IND For Pain Control; Sen. Cranston To Keynote Meeting On Centers

March 31, 1978

NCI CTEP Approved Trials For the Month of May

May 31, 2013

Senate Committee Investigating Pharma’s “Educational Grants.”

January 20, 2006

NIH, Lasker Foundation Offer Clinical Research Opportunity

December 10, 2010

FDA Approves Generic Oncology Injectable Currently In Shortage

September 27, 2013

In Brief: All 77 New NCI Positions Go to Carcinogenesis Programs; “Not Wisest Way To Use Them” – Newell

February 4, 1977